LFB joins the World Hemophilia Day 2019, today April 17th.
LFB completes the sale of CELLforCURE to Novartis
LFB strategic transformation project
CELLforCURE will produce innovative cancer CAR-T treatments for Novartis
Denis DELVAL is appointed CEO of LFB SA
The French State proposes Denis Delval as member of the Board in anticipation of his appointment as new LFB Group CEO
LFB’s fibrinogen and 10% immunoglobulin authorized for use in Europe
2017 Rare Disease Day : LFB’s commitment in the field of rare diseases